SNP - CYP1B1 Buccal Swab Add-On - Genova Test Kit
The SNP - CYP1B1 Buccal Swab Add-On - Genova Test Kit analyzes specific genetic variations in the CYP1B1 gene using DNA obtained from buccal cells.
Preparation:
Shipping samples Monday - Thursday only is recommended to avoid shipment delays. Overnight fasting is required. Patients should refrain from taking any medications or supplements until after collection. Consult with your physician prior to stopping any medications. Make sure to read and follow all collection instructions.
Test Results:
7-14 business days once the lab receives the specimen. May take longer based on weather, holiday, or lab delays.
Notice: This test can only be added to the Essential Estrogens - Hormone Test FMV (GD4209) and Essential Estrogens - Hormone Test 24-Hour (GD4210) test kits.
What is the purpose of this test?
The Genova Diagnostics' SNP - CYP1B1 Buccal Swab - Genova Test Kit is a highly advanced diagnostic tool that has been designed to analyze genetic variations in the CYP1B1 gene. This particular gene plays a critical role in the metabolism of drugs and toxins in the body. By studying the variations in this gene, the test can help healthcare professionals to tailor treatment plans and medications to a patient's unique genetic makeup, which can significantly improve the effectiveness of these treatments.
The test is performed using a simple buccal swab, a noninvasive procedure that involves collecting cells from the inside of the patient's cheek. The collected sample is then analyzed in a state-of-the-art laboratory using advanced genetic testing techniques to look for specific variations in the CYP1B1 gene. The results obtained from the test can provide valuable insights into a patient's potential response to certain medications and therapies and help healthcare professionals choose the most effective treatment plan for the individual.
Due to the precision and accuracy of the results obtained from the SNP - CYP1B1 Buccal Swab - Genova Test Kit, it has become an increasingly popular diagnostic tool among healthcare professionals worldwide. The test results can help identify patients who are at risk of developing adverse drug reactions or those who may require higher or lower doses of a particular medication to achieve the desired therapeutic effect. Overall, the Genova Diagnostics' SNP - CYP1B1 Buccal Swab - Genova Test Kit is a highly beneficial tool that can help healthcare professionals to provide personalized care to their patients based on their unique genetic makeup, leading to improved treatment outcomes and better patient health.
Benefits of the SNP - CYP1B1 Buccal Swab - Genova Test Kit:
- Genetic Insights: By analyzing variations in the CYP1B1 (cytochrome P450 1B1) gene, the kit provides valuable genetic insights into an individual's metabolism of various substances, including drugs, toxins, and hormones.
- Personalized Health Guidance: Knowledge of one's genetic predispositions allows for personalized health guidance, including tailored recommendations for medication selection, dosage adjustments, and lifestyle modifications to optimize health outcomes and reduce potential risks associated with impaired metabolism.
- Drug Metabolism Optimization: Understanding genetic variations in the CYP1B1 gene can aid in assessing an individual's response to medications metabolized by the cytochrome P450 system, including chemotherapy drugs, antidepressants, and hormone therapies, and guide strategies to optimize medication efficacy and minimize adverse effects.
- Detoxification Support: The test kit provides insights into how genetic variations in the CYP1B1 gene may influence detoxification processes, potentially impacting the body's ability to eliminate environmental toxins, carcinogens, and endogenous metabolites.
- Hormonal Regulation: CYP1B1 gene variations can also influence hormonal metabolism, including the activation and detoxification of estrogen compounds, which may have implications for reproductive health, cancer risk, and hormone-related conditions such as endometriosis and breast cancer.
